{"id":20233,"date":"2024-01-04T19:46:50","date_gmt":"2024-01-05T00:46:50","guid":{"rendered":"https:\/\/www.cornerstone.com\/?post_type=article&p=20233"},"modified":"2024-01-04T19:46:50","modified_gmt":"2024-01-05T00:46:50","slug":"most-favored-entry-clauses-in-drug-patent-litigation-settlements","status":"publish","type":"article","link":"https:\/\/www.cornerstone.com\/insights\/articles\/most-favored-entry-clauses-in-drug-patent-litigation-settlements\/","title":{"rendered":"Most-Favored Entry Clauses in Drug-Patent Litigation Settlements"},"content":{"rendered":"","protected":false},"featured_media":20219,"template":"","categories":[47,65],"tags":[],"asset_type":[32],"class_list":["post-20233","article","type-article","status-publish","has-post-thumbnail","hentry","category-antitrust-and-competition","category-life-sciences"],"acf":[],"yoast_head":"\n